Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU03807NANCT00701129Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme® Lumizyme®
Pompe Disease
AGLU06909/LTS13930NANCT01710813Abstract
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU07310NANCT01288027Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU07510NANCT01597596Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
AGLU09411NANCT01526785Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe Disease
ALGMYL08718APOLLO-IOPDEudraCT: 2021-004047-25Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme
Pompe's disease
ALGMYL09010(LPS15677)NAEudraCT Number: 2024-000461-24Tabulated Results
ALGLUCOSIDASE ALFA
Myozyme® Lumizyme®
Pompe Disease; Glycogen Storage Disease Type II (GSD II); Acid Maltase Deficiency Disease
LTS12869NANCT00486889Tabulated Results
ALGLUCOSIDASE ALFA
Lumizyme
Pompe Disease Glycogen Storage Disease Type II (GSD II)
MSC12790/ AGLU07710PAPAYA2010-022231-11Tabulated Results
ALIROCUMAB
Praluent
Acute Coronary Syndrome
ALIROL08069ODYSSEY J-IVUSNCT02984982Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted